NCT01414101View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Rheumatoid Arthritis
Interventions
DRUG

ISIS CRP Rx or Placebo

Trial Locations (10)

109240

Isis Investigational Site, Moscow

115522

Isis Investigational Site, Moscow

121374

Isis Investigational Site, Moscow

191104

Isis Investigational Site, Saint Petersburg

196247

Isis Investigational Site, Saint Petersburg

197022

Isis Investigational Site, Saint Petersburg

199106

Isis Investigational Site, Saint Petersburg

V2C1K7

Isis Investigational site, Kamloops

M9L 3A2

Isis Investigational Site, Toronto

2RV1V6

Isis Investigational Site, Montreal

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY